-+ 0.00%
-+ 0.00%
-+ 0.00%

Amylyx Pharmaceuticals Advances AMX0318 as Long-Acting GLP-1 Receptor Antagonist for Rare Diseases

路透·01/08/2026 12:00:45

登录查看新闻详情